BioMarin Pharmaceutical
Brendan Gildea is an accomplished professional in the pharmaceutical industry with extensive experience in quality assurance and operational management. Currently serving as QA Drug Substance Manager and Qualified Person at BioMarin Pharmaceutical Inc. since September 2022, Brendan previously held key roles at Novartis from March 2013 to December 2021, including QA Facilitator for Analytical Science & Technology, PU Facilitator, Launch Project Lead, and QA Compliance Manager, overseeing various critical projects and teams. Brendan’s educational background includes advanced degrees in Chemistry and Pharmaceutical Technology, complemented by a certificate in Supply Chain Management. This comprehensive expertise supports a strong focus on compliance, quality management, and operational excellence in pharmaceutical production.
This person is not in any teams
This person is not in any offices
BioMarin Pharmaceutical
42 followers
BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases.